Capabilities
Lipid Nanoparticles for Nucleic Acid Delivery
Polymeric Nanoparticles for Targeted Delivery
Polymeric Microspheres for Sustained Release Delivery
Services
Formulation Feasibility & Optimization
Process Development & Scale-up
Pre-clinical Batch Manufacturing
cGMP Manufacturing
Supporting Analytical Services
Solutions
Therapeutic Modalities
Drug Payloads
Drug Carriers
Resources
About
News
Events
Careers
Contact Us
Home
Resources
Case Study: Development of Nanoparticles for the Systemic Delivery of Antisense Oligonucleotides to the Central Nervous System
Case Study: Development of Nanoparticles for the Systemic Delivery of Antisense Oligonucleotides to the Central Nervous System
Phosphorex’s director of nucleic delivery presents on Nanoparticles for the delivery of ASO to the CNS.
Click here to view the webinar
Webinar
News
Login
Login
Password
Register
Username*
Password*
First Name*
Last Name*
Email*
File Name
Select File
Image (88x80)
Previous Post
Development of Long-Acting Injectable Microspheres
Next Post
PPRX-1701, a nanoparticle formulation of 6- bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models